Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» OncoMed stock plunges after negative findings by study monitoring board
OncoMed stock plunges after negative findings by study monitoring board
OncoMed stock plunges after negative findings by study monitoring board
Submitted by
admin
on January 25, 2016 - 9:53am
Source:
Marketwatch
News Tags:
OncoMed
tarextumab
GSK
clinical trials
Headline:
OncoMed stock plunges after negative findings by study monitoring board
Do Not Allow Advertisers to Use My Personal information
